Stay updated on Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial
Sign up to get notified when there's something new on the Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial page.

Latest updates to the Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page footer shows a new revision entry (v3.3.3) and the HHS Vulnerability Disclosure link plus an older revision entry (v3.3.2) were removed. This is a minor UI/versioning change with no impact on study data.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the government funding status notice at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe old and new screenshots show the same list of version history entries, with no changes to core trial data, status, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedThe new version (58) was added on 2025-10-23, and the Study Status section was updated.SummaryDifference0.2%

- Check90 days agoChange DetectedThe page now communicates a funding-related operating-status notice and confirms the center is open, plus a new version identifier v3.2.0, replacing v3.1.0.SummaryDifference9%

Stay in the know with updates to Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enzalutamide Combo vs Placebo in Chinese mHSPC Clinical Trial page.